Published in Eur J Epidemiol on March 19, 2009
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
The Generation R Study: design and cohort update 2010. Eur J Epidemiol (2010) 1.85
Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab (2011) 1.23
The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol (2010) 0.96
Standards for reporting randomized controlled trials in medical informatics: a systematic review of CONSORT adherence in RCTs on clinical decision support. J Am Med Inform Assoc (2011) 0.90
Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol (2011) 0.85
Leisure time physical activity in adulthood is positively associated with bone mineral density 22 years later. The Tromsø study. Eur J Epidemiol (2010) 0.82
New studies, technology, and the progress of epidemiology. Eur J Epidemiol (2010) 0.81
Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures. Osteoporos Int (2015) 0.81
The efficacy and safety of a combined alendronate and calcitriol agent (maxmarvil): a postmarketing surveillance study in korean postmenopausal women with osteoporosis. Korean J Fam Med (2012) 0.78
External validation of the Garvan nomograms for predicting absolute fracture risk: the Tromsø study. PLoS One (2014) 0.77
Bone mineral density is associated with vitamin D related rs6013897 and estrogen receptor polymorphism rs4870044: The Tromsø study. PLoS One (2017) 0.75
Different reference BMDs affect the prevalence of osteoporosis. J Bone Miner Metab (2015) 0.75
Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res (1997) 5.69
Assessment of fracture risk. Osteoporos Int (2004) 5.15
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int (2004) 4.24
A reference standard for the description of osteoporosis. Bone (2007) 3.67
Do we need to change the WHO definition of osteoporosis? Osteoporos Int (2000) 3.35
International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res (2002) 3.14
Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09
An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int (2000) 2.99
Pathogenesis of bone fragility in women and men. Lancet (2002) 2.64
Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res (2003) 2.61
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone (2008) 2.53
Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ (1997) 2.18
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone (2000) 1.89
Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res (1995) 1.77
Exercise in preventing falls and fall related injuries in older people: a review of randomised controlled trials. Br J Sports Med (2000) 1.75
Age-related decrements in bone mineral density in women over 65. J Bone Miner Res (1992) 1.69
Proximal femur bone mineral levels of US adults. Osteoporos Int (1995) 1.69
Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int (2000) 1.66
Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol (1998) 1.56
Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ (1994) 1.51
Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res (1997) 1.42
Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res (1992) 1.34
Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int (2007) 1.22
The prevalence of osteoporosis: gender and racial comparison. Calcif Tissue Int (2001) 1.20
Epidemiology of hip fractures in 2002 in Rabat, Morocco. Osteoporos Int (2004) 1.16
Epidemiology of hip fractures in Norway. Acta Orthop Scand (1985) 1.15
Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int (2004) 1.14
Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int (2001) 1.12
Epidemiology of fractures of the distal forearm in Oslo, Norway. Acta Orthop Scand (1983) 1.11
Determinants of bone mineral density in older men. J Bone Miner Res (1995) 1.07
Diagnosis and epidemiology of osteoporosis. Curr Opin Rheumatol (2005) 1.07
Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int (2000) 1.04
International comparison of hip fracture rates in 1988-89. Osteoporos Int (1996) 1.02
Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res (2004) 1.00
Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study. Osteoporos Int (2005) 1.00
Longitudinal changes in forearm bone mineral density in women and men aged 25-44 years: the Tromsø study: a population-based study. Am J Epidemiol (2005) 0.99
Body mass index is not a good predictor of bone density: results from WHI, CHS, and EPIDOS. J Clin Densitom (2006) 0.96
Epidemiology of osteoporosis and fracture in men. Calcif Tissue Int (2004) 0.94
Fractures of the distal radius in a Norwegian city. Scand J Plast Reconstr Surg Hand Surg (1995) 0.88
Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporos Int (2004) 0.87
Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis. J Clin Densitom (2008) 0.87
Prevalence of osteoporosis and related risk factors in UK women in the seventh decade: osteoporosis case finding by clinical referral criteria or predictive model? Osteoporos Int (1998) 0.84
In vivo and in vitro comparison of densitometers in the NOREPOS study. J Clin Densitom (2007) 0.82
Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population. Osteoporos Int (2004) 0.81
Magnitude and determinants of premenopausal bone loss. Osteoporos Int (1994) 0.80
Assessment of involutional bone loss: methodological and conceptual problems. J Bone Miner Res (1995) 0.75
Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol (2010) 2.66
Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res (2011) 1.59
Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol (2010) 1.54
Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials. Scand J Infect Dis (2011) 1.52
Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr (2010) 1.40
Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension (2010) 1.30
No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine (2010) 1.26
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One (2012) 1.23
Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int (2005) 1.22
Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol (2010) 1.16
Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand J Clin Lab Invest (2014) 1.14
The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol (2013) 1.13
Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006-2011. BMC Infect Dis (2013) 1.12
A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study. Eur J Endocrinol (2007) 1.05
Lifestyle impact on lifetime bone loss in women and men: the Tromsø Study. Am J Epidemiol (2009) 1.01
Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine (2012) 1.00
Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol (2012) 0.97
Progressively increasing fracture risk with advancing age after initial incident fragility fracture: the Tromsø study. J Bone Miner Res (2013) 0.96
No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year. Nutr J (2010) 0.96
Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromsø. ISRN Endocrinol (2013) 0.94
Low serum levels of 25-hydroxyvitamin D predict hip fracture in the elderly: a NOREPOS study. J Clin Endocrinol Metab (2013) 0.93
More forearm fractures among urban than rural women: the NOREPOS study based on the Tromsø study and the HUNT study. J Bone Miner Res (2011) 0.90
A case study of an EMR system at a large hospital in India: challenges and strategies for successful adoption. J Biomed Inform (2011) 0.90
Impacts of body mass index, physical activity, and smoking on femoral bone loss: the Tromsø study. J Bone Miner Res (2014) 0.89
The Tromsø Study: Fit Futures: a study of Norwegian adolescents' lifestyle and bone health. Arch Osteoporos (2014) 0.86
Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol (2013) 0.85
Vitamin D and lipids: do we really need more studies? Circulation (2012) 0.83
Self-reported diseases and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int (2005) 0.82
Impact of comorbidity, age, and gender on seasonal variation in hip fracture incidence. A NOREPOS study. Arch Osteoporos (2014) 0.82
Associations between polymorphisms related to calcium metabolism and human height: the Tromsø Study. Ann Hum Genet (2012) 0.80
Vitamin D and intraocular pressure--results from a case-control and an intervention study. Acta Ophthalmol (2013) 0.80
Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women. Eur J Nutr (2011) 0.79
Age and Sex Differences in Body Mass Index as a Predictor of Hip Fracture: A NOREPOS Study. Am J Epidemiol (2016) 0.78
Validation of the Cummings' risk score; how well does it identify women with high risk of hip fracture: the Tromsø Study. Eur J Epidemiol (2006) 0.78
Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D levels at baseline, but not affected during supplementation with vitamin D. Thromb Res (2010) 0.76
The phosphodiesterase 8B gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: the Tromsø study. Thyroid (2013) 0.75